Four-Drug attack on tough bile duct cancer
NCT ID NCT06893380
Summary
This trial is testing a new combination of four drugs for people with advanced bile duct cancer that cannot be removed by surgery. The goal is to see if adding two newer drugs (Nab-paclitaxel and Tislelizumab) to a standard chemotherapy pair can better control the cancer and help patients live longer. The study will first find the safest dose and then measure how well the treatment shrinks tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BILIARY TRACT CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHA Bundang Medical Center
RECRUITINGSeongnam-si, Gyeonggi-do, 13496, South Korea
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.